Tenet Healthcare (THC) Reports Q3 EPS of 36c, Raises FY14 EBITDA Outlook

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $0.36, may not compare to the analyst estimate of $0.10. Revenue for the quarter came in at $4.18 billion versus the consensus estimate of $4.02 billion.

Tenet Healthcare sees FY2014 EPS of $1.26-$1.78,may not compare to the consensus of $1.42.

The Outlook range for 2014 Adjusted EBITDA is in a range of $1.90 to $1.95 billion, a $25 million mid-point increase as compared to the Company’s prior Outlook of $1.85 to $1.95 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman starts Talen at buy, sees PJM power tightness boosting earnings
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS